Hims’s chief commercial officer, he leaned hard into words such as normalization and empower. I told him that the constant barrage of Hims ads had made me feel almost bullied into doing ...

The minute-long ad from telehealth company Hims & Hers ... to lawfully marketed compounded drugs for patients." Before Hims & Hers' commercial even aired, Democratic Sen. Dick Durbin of Illinois ...

Pharma lobby group The Pharmaceutical Research and Manufacturers of America (PhRMA) called HIMS’ commercial “a misleading Super Bowl ad that misrepresents their unapproved GLP-1 medicines.” ...

The telehealth company is being criticized for its Super Bowl weight loss commercial. (Hims & Hers via YouTube) ...

“The recent explosion in irresponsible and misleading advertising about compounded GLP-1 (glucagon-like peptide-1) drugs, like the Hims & Hers Super Bowl commercial, puts patients’ safety at ...

A TV commercial that the telehealth company Hims & Hers Health (NYSE ... dubbed it as “a misleading ad,” and the public health group the Partnership for Safe Medicines (PSM) called it an ...

Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the Super Bowl. The commercial's airing raised concerns from health experts ...

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy. The ad criticized the ...

Investing.com -- Shares of Hims and Hers (NYSE:HIMS) climbed 5% despite facing criticism over a Super Bowl advertisement for its generic weight-loss drugs. The ad, which highlights the company's ...